The use of cardiac progenitor cells for transplantation in congenital heart disease and an innovative strategy for activating mitochondrial function in such cells

Prior to the 20th century, most cardiologists assumed that the mammalian heart had no regenerative ability once the myocardium was injured as the result of a pathological event, such as ischemia.